Barely Significant
← all excerpts

High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.

Cancer Sci · 2022 · PMC8819333 · PMID 34843149

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

marginal significanceP = .050actually significant
In total, 4 AAbs showed significantly higher levels ( P < .05) in non‐TN than those in the TN subtype and anti‐GARS displayed marginal significance ( P = .050) between non‐TN and TN subtypes (Figure 6A ).

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.